Fertilitate
Published 21 Jul, 2026
9 min. read

Fertility After 40: What Should Be Understood Before a Treatment Plan

After 40, fertility should be evaluated quickly, with attention to time, ovarian reserve, oocytes and realistic options.

Fertility After 40: What Should Be Understood Before a Treatment Plan

Fertility after 40 does not mean the same thing for all patients. I meet women with regular cycles, apparently good test results and a discreet medical history, but also patients for whom time, ovarian reserve or previous treatments quickly change the direction of the discussion. This is why the first thing I explain is that age should not be seen as a label, but as a medical factor that influences the speed and type of decisions.

In my practice, fertility after 40 mainly means clarity. It is not enough to say “let’s try and see what happens” if there are signs that ovarian reserve is reduced or that the couple’s history requires a more active approach. To better understand the context of age in assisted reproduction, I have explained separately how things change from one age interval to another, without this article being about statistics or success rates.

Here, I want to discuss medical strategy: what we evaluate, what should not be delayed, when a plan with the patient’s own oocytes makes sense and when it is correct to discuss other options as well.

After 40, time becomes part of the diagnosis

After 40, time is no longer only a personal life variable. It becomes a medical element. I consider it together with the duration of trying to conceive, ovulation regularity, test results, the partner’s semen analysis, gynecological history and any previous treatments.

I frequently tell patients that fertility after 40 is not evaluated through one isolated test. A hormonal value may guide the discussion, but it cannot describe on its own the real chances, the right rhythm or the best therapeutic path. This is why, during the consultation, I try to avoid two extremes: panic and waiting for too long.

There are situations in which I recommend a complete evaluation without delay, especially if pregnancy has not occurred after a few months of trying, if menstruation has changed, if there is endometriosis, ovarian surgery, pregnancy losses or if the patient has already undergone fertility treatments without success. In these cases, the question is not only “is it still possible?”, but “what is the most logical step now?”.

Ovarian reserve shows quantity, but does not promise quality

In discussions about fertility after 40, ovarian reserve almost always comes up. AMH, ultrasound with antral follicle count and menstrual cycle history help us estimate how the ovaries may respond to stimulation. However, I explain every time that ovarian reserve mainly speaks about quantity and possible response, but it does not guarantee oocyte quality.

A patient may have an AMH value that is acceptable for her age, but the oocytes are still influenced by biological age. Conversely, a reduced reserve does not automatically mean that any attempt is useless, but it does mean that the plan must be built realistically, without losing months in strategies that do not bring information or progress.

Why oocyte quality changes the medical discussion

Oocyte quality influences fertilization, embryo development, implantation and the risk of pregnancy loss. After 40, we do not discuss only how many oocytes can be obtained, but also the probability that they can support a developing embryo.

For this reason, fertility after 40 must be viewed as a combination of time, ovarian biology and the patient’s objective. When I explain these things, I try to keep a balance: not to discourage unnecessarily, but also not to create unrealistic expectations. A good plan does not promise what medicine cannot guarantee, but uses the available information correctly.

What I look for before recommending a treatment plan

Before any recommendation, I look at the full context. I do not make the decision only based on age, and not only based on AMH. It matters whether ovulation is present, what the uterus looks like, whether the fallopian tubes have been evaluated when relevant, what the semen analysis shows and how much time has passed without pregnancy.

In practical terms, I am interested in several directions:

  • whether there are reasonable chances for monitored natural attempts;
  • whether time lost by waiting may significantly reduce the available options;
  • whether In Vitro Fertilization is a logical option at that moment;
  • whether additional investigations should be discussed before treatment;
  • whether there are already signs that the patient’s own oocytes may offer a very limited prognosis.

For some couples, the recommendation is not to rush toward procedures without a correct evaluation. For others, I recommend not extending the waiting period unnecessarily. I have detailed this difference in the article about the moment when IVF becomes a rational option or may be postponed, because the decision depends greatly on context.

When the decision should be made faster and when there is still room to wait

In fertility after 40, waiting can have a biological cost. I do not say this to create pressure, but because it is important for the patient to understand that each month may matter differently at 30, 38 or 42.

There are situations in which we may still monitor a few cycles, especially if the evaluation is good, the duration of trying is short and there are no obvious risk factors. But there are also situations in which I recommend moving faster toward an active plan: reduced ovarian reserve, age over 42, a history of repeated failures, abnormal semen analysis or a long duration of infertility.

I explain to patients that the decision should not be made out of fear. It should be made based on information. Fertility after 40 is a sensitive topic precisely because it touches important personal plans, but medicine requires us to remain clear-headed. A good treatment plan is not necessarily the most aggressive one, but the one most suited to the available biological window. nu este neapărat cel mai agresiv, ci cel mai potrivit pentru fereastra biologică disponibilă.

“You deserve to be heard, seen, treated with respect and supported throughout your life.”

Ilustrație cu Dr. Andreas Vythoulkas oferind sprijin și îngrijire personalizată unei paciente în cadrul tratamentelor FIV.
Ilustrație cu o femeie însărcinată reprezentând succesul tratamentelor de fertilitate oferite de Dr. Andreas Vythoulkas.

When we discuss donated oocytes, without haste and without pressure

In some cases, fertility after 40 leads to a difficult discussion: the use of donated oocytes. I do not introduce this option as a quick conclusion and I do not present it as an obligation. I discuss it when the medical data show that the chances with the patient’s own oocytes are very low or when there have been repeated attempts without viable embryos.

It is important for the patient or couple to understand the difference between the uterus’s ability to carry a pregnancy and the quality of the available oocytes. In many situations, the uterus can be evaluated and prepared, but the main problem remains the oocyte. This is where the difference appears between continuing with the patient’s own oocytes and considering IVF with donated oocytes as a distinct medical option.

From my clinical experience, this discussion must be carried with patience. It is not only a medical decision, but also an emotional one. My role is to explain the data, limits, steps and implications, not to push the patient in a direction for which she is not ready.

At the same time, when treatment is reached, I consider it useful for the patient to understand concretely what the pathway involves. This is why, for a clearer picture of the stages, monitoring and experience during the procedure, it may be useful to read about how the patient’s pathway unfolds during IVF treatment.

Frequently Asked Questions

Is natural pregnancy still possible after 40?
Yes, it is possible, but the probability decreases with age, especially through the reduction in oocyte quality and the increased risk of less predictable ovulation. In the evaluation, I do not rely only on the theoretical possibility, but on the patient’s concrete context: exact age, duration of trying, ovulation, ovarian reserve, semen analysis and medical history.

How long should a woman over 40 wait before evaluation?
In general, after 40 I recommend that evaluation should not be delayed. If pregnancy is desired, a few months may be medically relevant. This does not automatically mean that In Vitro Fertilization will be needed, but it does mean that it is more prudent to understand the real options quickly.

Can AMH show whether I will become pregnant?
AMH helps estimate ovarian reserve and the possible response to stimulation, but it cannot predict pregnancy on its own. In fertility after 40, AMH must be interpreted together with age, ovarian ultrasound, reproductive history and the other factors of the couple.

Is IVF always the first recommendation after 40?
Not always. There are patients for whom monitoring, additional investigations or other approaches can be discussed before In Vitro Fertilization. However, if there are risk factors or the duration of infertility is significant, IVF may become a faster recommendation in order not to lose a valuable biological window.

Can oocyte quality be improved through supplements or lifestyle changes?
A balanced lifestyle can support general and reproductive health, but it cannot reverse the effect of age on oocytes. I recommend caution toward absolute promises. Supplements or lifestyle changes may have a supportive role, but they should not replace medical evaluation and timely decisions.

When are donated oocytes discussed?
This discussion appears when the chances with the patient’s own oocytes are very low, when ovarian response is poor or when previous treatments have not led to viable embryos. It is an important medical option, but it must be explained calmly, with respect for the emotional rhythm of the patient or couple.

The role of Dr. Andreas Vythoulkas in fertility evaluation after 40

My role in fertility after 40 is to place the information in a clear order. The patient does not need vague hopes, but she also does not need harsh conclusions formulated too quickly. She needs careful evaluation, honest medical explanations and a plan that takes into account time, ovarian reserve, oocyte quality, the couple’s history and the reproductive goal.

During the consultation, I aim to differentiate between situations in which there is still room for monitoring and those in which I recommend a faster decision. I explain what can be tried, what limits exist and when it is correct to discuss alternatives. For me, fertility after 40 does not mean one single solution, but a strategy built responsibly, with respect for the patient and with medical realism.

Contact me

Talk to me about
fertility after 40

If you have questions about fertility after 40 or are concerned about your fertility, you can request a dedicated discussion at any time. An individual evaluation helps clarify the available options and establish a treatment plan adapted to your personal needs.

Sources